Trends in the adoption of robotic technology for radical cystectomy: A population-based analysis.

2012 ◽  
Vol 30 (5_suppl) ◽  
pp. 311-311
Author(s):  
Steven Lee Chang ◽  
Wei Jiang ◽  
Benjamin I. Chung

311 Background: The adoption of the da Vinci Surgical System (Intuitive Surgical, Inc.) for robotic surgery requires a substantial financial investment by hospitals, acquisition of new surgical skills by surgeons, and demand from patients. Although the benefits of this technology have been previously described, the prevalence and adoption rate for robotics in the management of bladder cancer is not currently known. We performed a population-based analysis to determine how the introduction of robotic technology has altered the surgical management of bladder cancer. Methods: We analyzed patient-level data from the Prospective Rx Comparative Database (Premier, Inc., Charlotte, NC), which collects data from over 600 non-federal hospitals throughout the United States. We captured all patients who underwent a radical cystectomy with a diagnosis of bladder cancer between January 1, 2003, and December 31, 2010, based on codes from the International Classification of Disease, 9th edition. Radical cystectomies utilizing the da Vinci Surgical System were identified by a detailed review of the hospital charge data. Results: There was an increase in an overall adoption of robotic radical cystectomy from <2% in 2003 to 23% in 2010. Since 2005, teaching hospitals had a relative increased utilization of robotic radical cystectomy by approximately 40% each year compared to non-teaching hospitals. Hospitals in the West had the highest odds (odds ratio [OR] 3.1, p<0.001 [vs Midwest]) of utilizing robotic surgery for radical cystectomy while larger hospitals (>200 beds) were more likely to adopt robotic technology for radical cystectomy (OR 1.78, p<0.0001). Conclusions: There has been a relatively rapid adoption of the da Vinci Surgical System in the performance of radical cystectomy. This increased utilization is potentially secondary to the acquisition of robotic surgical skills and familiarity with transperitoneal pelvic anatomy following the widespread use of robotic technology for radical prostatectomy during the same time period.

2012 ◽  
Vol 30 (5_suppl) ◽  
pp. 258-258
Author(s):  
Steven Lee Chang ◽  
Wei Jiang ◽  
Benjamin I. Chung

258 Background: The adoption of the da Vinci Surgical System (Intuitive Surgical, Inc) for robotic surgery requires a substantial financial investment by hospitals, acquisition of new surgical skills by surgeons, and demand from patients. Although the benefits of this technology have been previously described, the prevalence and adoption rate for the treatment of prostate cancer is not currently known. We performed a population-based analysis to determine how the introduction of robotic technology has altered the surgical management of prostate cancer. Methods: We analyzed patient-level data from the Prospective Rx Comparative Database (Premier, Inc., Charlotte, NC), which collects data from over 600 non-federal hospitals throughout the United States. We captured all men who underwent a radical prostatectomy between January 1, 2003, and December 31, 2010, based on the International Classification of Disease, 9th edition. Radical prostatectomies utilizing the da Vinci Surgical System were identified by a detailed review of the hospital charge data. Descriptive analysis with univariate and multivariate statistical analyses were performed. Results: Prior to 2006, <10% of radical prostatectomies were performed with robotic surgery. Beginning in 2006 there was a rapid rise in adoption reaching 56% utilization in 2009 and leveling off in 2010 to 54%. Adjusted analysis demonstrated that the odds of adopting robotic surgery were higher in teaching hospital (odds ratio [OR] 1.45, p<0.001) and hospitals in the Northeast (vs Midwest [OR 2.99, p<0.001]). Smaller hospitals (<200 beds) had a lower likelihood of adopting robotic surgery (OR 0.4, p<0.001). Patient age had no impact on the odds of undergoing robotic radical prostatectomy. Conclusions: Over past 5 years, there has been widespread adoption of robotic surgery in the management of prostate cancer now with just over half of procedures performed with the da Vinci Surgical System. Our analysis suggests that the adoption of robotic surgery has been determined primarily by the acquisition of this technology by hospitals, which was more common in teaching institutions, larger hospitals, and hospitals in the Northeast.


2005 ◽  
Vol 84 (3) ◽  
pp. 170-172 ◽  
Author(s):  
Ian K. McLeod ◽  
Patrick C. Melder

The da Vinci Surgical System is a new and exciting entrant into the field of robotic technology. This system is undergoing considerable research and is being practically applied in general surgery, cardiothoracic surgery, urology, and gynecology. We have previously described our experience with the da Vinci system in the laboratory setting, and we have reviewed its potential applications in otolaryngology. Here we present a case report of the first da Vinci-assisted excision of a vallecular cyst in a human. Although we initially encountered some difficulties in the setup, we were able to perform the procedure with moderate ease and without complication. The potential of the da Vinci system in otolaryngology is promising. Further research is needed to explore all of its possible uses in our field.


Author(s):  
Braden Millan ◽  
Shavy Nagpal ◽  
Maylynn Ding ◽  
Jason Y. Lee ◽  
Anil Kapoor

Objectives Since the introduction of the first master–slave robotic platform for surgical procedures, there have been ongoing modifications and development of new platforms, but there is still a paucity of commercially available systems. Our study aims to identify all master–slave robotic surgical platforms currently commercially available or in development around the world with applications in urologic surgery. Methods A scoping literature search was performed using PRISMA methodology to identify all relevant publications in English in PubMed, PubMed Central, and Embase, with additional information being obtained from official company websites. Results Ten robotic platforms with either proven or potential application in urologic surgery were identified: the da Vinci surgical system (Intuitive), Senhance surgical system (Transentrix), Versius Surgical (CMR Ltd), Enos surgical system (Titan Medical), Revo –I (Meere Company), MiroSurge (DLR), Avatera System (Avatera Medical), Hugo Surgical Robot (Medtronic), Ottava (J&J, Ethicon, Areus), and Hinotori (Medicaroid Corporation). Conclusions This review highlights the distinct features of emerging master–slave robotic platforms with applications in urologic surgery. Research and development are now focused on finding wider applications, improving outcomes, increasing availability, and reducing cost. Additional research is required comparing newly developed master–slave robotic platforms with those already well established.


2011 ◽  
Vol 36 (5) ◽  
pp. 496-498 ◽  
Author(s):  
Norihiko Ishikawa ◽  
Masahiko Kawaguchi ◽  
Hideki Moriyama ◽  
Nobuhiro Tanaka ◽  
Go Watanabe

Retina ◽  
2008 ◽  
Vol 28 (1) ◽  
pp. 154-158 ◽  
Author(s):  
DAN H. BOURLA ◽  
JEAN PIERRE HUBSCHMAN ◽  
MARTIN CULJAT ◽  
ANGELO TSIRBAS ◽  
ANURAG GUPTA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document